Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | RGC | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 216.81 | 26.15 | 25.50 | ||
| High | 217.11 | 26.21 | 26.00 | ||
| Low | 215.02 | 25.97 | 23.60 | ||
| Latest | 219.58 | 25.98 | 24.37 | ||
| Change | +2.63 | +0.16 | -1.30 | ||
| % Change | +1.21% | +0.62% | -5.06% | ||
| Volume | 30,001 | 155,141 | 23,779 | ||
| 20-Day Average Volume | 517,135 | 1,603,402 | 126,040 | ||
| Previous Close | 216.95 | 25.82 | 25.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 228.14 | 26.54 | 24.68 | ||
| 20-Day Raw Stochastic | 12.12% | 35.61% | 42.63% | ||
| 20-Day Relative Strength | 43.98 | 38.79 | 46.83 | ||
| Weighted Alpha | +41.91 | +24.70 | +18.13 | ||
| Today's Opinion | 40% Buy | 72% Sell | 40% Buy | ||
| Previous Opinion | 40% Buy | 72% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.50% since 03/23/26 | +1.73% since 03/23/26 | -4.62% since 03/23/26 | ||
| Low | 212.60 on 03/24/26 | 25.42 on 03/24/26 | 23.52 on 03/27/26 | ||
| High | 237.81 on 03/26/26 | 26.47 on 03/27/26 | 27.18 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -7.08% since 02/27/26 | -11.26% since 02/27/26 | -8.31% since 02/27/26 | ||
| Low | 212.60 on 03/24/26 | 24.95 on 03/20/26 | 20.00 on 03/09/26 | ||
| High | 248.60 on 03/03/26 | 29.85 on 03/02/26 | 29.50 on 03/18/26 | ||
| 3-Month | |||||
| %Chg | +3.82% since 12/26/25 | -21.83% since 12/26/25 | +13.66% since 12/26/25 | ||
| Low | 188.08 on 01/12/26 | 24.95 on 03/20/26 | 19.80 on 12/29/25 | ||
| High | 248.60 on 03/03/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +13.01% since 09/26/25 | -10.13% since 09/26/25 | +59.27% since 09/26/25 | ||
| Low | 186.05 on 10/20/25 | 24.95 on 03/20/26 | 10.33 on 11/25/25 | ||
| High | 248.60 on 03/03/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,445,910 | 16,589,531 | 12,693,532 | ||
| Shares Outstanding, K | 61,977 | 642,507 | 494,489 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 0 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -3,580,000 | ||
| Last Quarter Sales | 279,270,000 | 1,058,000,000 | N/A | ||
| Last Quarter Net Income | -42,910,000 | 31,000,000 | N/A | ||
| 60-Month Beta | 0.43 | 0.94 | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 02/11/26 | 0.05 on 02/17/26 | N/A | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 01/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.79 | 0.00 | ||